SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-050865
Filing Date
2020-11-05
Accepted
2020-11-05 07:21:08
Documents
68
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q srra-10q_20200930.htm 10-Q 2235178
2 EX-31.1 srra-ex311_8.htm EX-31.1 10038
3 EX-31.2 srra-ex312_7.htm EX-31.2 10037
4 EX-32.1 srra-ex321_6.htm EX-32.1 6819
5 EX-32.2 srra-ex322_9.htm EX-32.2 6762
  Complete submission text file 0001564590-20-050865.txt   7185255

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT srra-20200930.xml EX-101.INS 1502673
7 XBRL TAXONOMY EXTENSION SCHEMA srra-20200930.xsd EX-101.SCH 51481
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srra-20200930_cal.xml EX-101.CAL 42689
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srra-20200930_def.xml EX-101.DEF 173641
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20200930_lab.xml EX-101.LAB 395393
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20200930_pre.xml EX-101.PRE 304977
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37490 | Film No.: 201288668
SIC: 2834 Pharmaceutical Preparations